Join Dr. Michael Mitar for a discussion surrounding the care of COPD patients in 2022 and overcoming obstacles in the treatment pathway presented through COVID.
By watching this webinar, you will learn about:
✓ Updated COPD guidelines
✓ New options in medications
✓ Non pharmacotherapeutic treatment options
✓ Spirometry access
Enter your information below to watch a recording of the webinar:
This article describes the generative, patient-centered, design process used in the development of a prototype VHC intended primarily for use ‘on the go’ by adults with persistent asthma or newly diagnosed COPD.
More consistent dose delivery was achieved with the breath actuated technology rather than breath enhanced. Delivering medication only when the patient inhales would result in more stable therapy if I:E ratio was to change with disease< progression or if the patient took breaks to talk during treatment.
COPD is a chronic and progressive disease that requires regular self-administration of inhaled medications. However, as the disease progresses, reduced respiratory muscle strength may prevent patients from generating sufficient inspiratory effort to effectively use dry-powder inhalers (DPIs) [1, 2]. In contrast, patients can inhale slowly or breathe tidally from a pMDI with VHC without the need to coordinate with inhaler actuation [3].
Join Dr. Sacha Bhinder, HBSc, MD, FRCPC, for a review of inhaled delivery device products that are available in Canada, and how to foster customized care when choosing the most appropriate device for your patient.
The continuous involvement of patients resulted in a number of key insights that helped guide the design process, resulting in the development of a chamber that patients are much more likely to use while on-the-go.
As current MDIs contain hydrofluorocarbon propellants, it would be beneficial to find ways to reduce carbon emissions without compromising patient safety.
This lab study investigated a way to optimize the modelled lung dose per actuation while at the same time minimizing the carbon emissions from the MDI
The FRI deposition profiles highlight that the MDI/AeroChamber Plus* Flow-Vu* VHC delivered a significantly greater percentage of drug to the lung region than either of the two DPIs, irrespective of flow rate.
This was reflected in much higher modelled oropharyngeal deposition for the two DPIs.
The influence of inhalation flow profile was significant for one of the DPIs.
This laboratory and clinical overview demonstrates appreciable differences in pressure pulse waveforms for differing OPEP devices and then links these for the leading laboratory performing device into reported airway physiological changes and improved clinical outcomes.
Joignez-vous à David Gourde, Inf. et CRE, pour une discussion sur comment vous pouvez aider vos patients à libérer leurs poumons avec un traitement non-pharmacologique.
Cette session a été établie en partenariat avec Alliance Pharma.
Votre conférencier : David Gourde, Inf. B. Sc. CRE Intervenant pivot-réseau en maladies pulmonaires chroniques
Nouveautés Loi 31 – Enfin! Mais comment faire mieux avec nos patients en santé respiratoire?
L’ajout récent des prises en charge pour l’asthme et la MPOC dans les actes de la Loi 31 est une opportunité intéressante et rentable d’améliorer la santé respiratoire des patients. Ce webinaire vous permettra de mettre à jour vos connaissances en santé respiratoire, d’obtenir des outils pratiques afin de réaliser ces actes dans vos pharmacies et d’apprivoiser leur facturation. Un événement à ne pas manquer!
Join Professor Omar Usmani and Dr. John Pritchard as they review the environmental impact of inhaled medications. Tune in to discover how to develop patient centric strategies to reduce the impact of inhalers on the climate.
This conversation will cover:
Climate change and carbon impact of pressurised Metered Dose Inhalers (pMDIs)
Join Dr. Omar Usmani as he discusses the importance of proper inhaler technique and technique check-ups, as well as inhaler management during COVID-19 and the role that spacers play in asthma control.
Join Dr. Douglas Mack and Dr. Mariam Hanna as they discuss the importance of asthma control in today’s world, as well as the shift to virtual appointments including tools and tips to optimize virtual asthma assessments. Please see a recording of the session below.
